Rockwell Medical (RMTI) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Rockwell Medical (RMTI) over the last 16 years, with Q3 2025 value amounting to -$0.05.
- Rockwell Medical's EPS (Weighted Average and Diluted) fell 22500.0% to -$0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year decrease of 20000.0%. This contributed to the annual value of -$0.02 for FY2024, which is 9517.91% up from last year.
- Rockwell Medical's EPS (Weighted Average and Diluted) amounted to -$0.05 in Q3 2025, which was down 22500.0% from -$0.05 recorded in Q2 2025.
- In the past 5 years, Rockwell Medical's EPS (Weighted Average and Diluted) registered a high of $0.04 during Q3 2024, and its lowest value of -$1.04 during Q4 2021.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.31, with a median of -$0.07 in 2023.
- In the last 5 years, Rockwell Medical's EPS (Weighted Average and Diluted) plummeted by 105555.56% in 2021 and then skyrocketed by 15714.29% in 2024.
- Over the past 5 years, Rockwell Medical's EPS (Weighted Average and Diluted) (Quarter) stood at -$1.04 in 2021, then surged by 95.19% to -$0.05 in 2022, then grew by 0.0% to -$0.05 in 2023, then soared by 49.84% to -$0.03 in 2024, then tumbled by 99.35% to -$0.05 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.05 in Q3 2025, compared to -$0.05 in Q2 2025 and -$0.04 in Q1 2025.